Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV:
$KHRN.V) (TSX: $APHA.TO) (NYSE: $APHA) (TSXV: $VGW.V)
(TSXV: $META.V)
(CSE: $OH.C)
Delta, Kelowna, BC –October 16, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/10161KHRN-APHA-VGW-META-OH.asp
Good afternoon and welcome to another episode of
Investorideas.com "Potcast" featuring cannabis news, stocks to watch
as well as insights from thought leaders and experts
In today’s
podcast we look at announcements from earlier this week.
But
first, StrainprintR Technologies
Ltd. announced that Health Canada has subscribed to use
Strainprint Analytics to further research Canadians' use of cannabis in the
post-legalization era.
Health
Canada views the legalization and regulation of all cannabis through a lens of
public safety and is regarded as one of the most respected regulatory bodies in
the world. Raising awareness about the health effects of cannabis through
research and public education is fundamental to Health Canada's mandate, which
Strainprint's real-world observational data is uniquely positioned to support.
Health
Canada now has access to over 1.4 million anonymized patient reported outcomes
(70+ million data points on real-time patient use and strain efficacy) through
Strainprint Analytics, the most sophisticated cannabis research platform
available today. Strainprint Analytics is the self-serve web-companion to
published reports (like the
Canadian Medical Cannabis Experience: A
2019 Patient Retrospective) and
custom research that Strainprint's research team conducts on its data for
industry.
Various
departments at Health Canada will use Strainprint Analytics to:
● Understand how optimal products and
administration methods vary by gender and age across the country;
● See how products and producers rank against
each other for consistency and efficacy;
● Get better and faster visibility into any
adverse reactions; and
● Track how Candian patient use has changed
pre and post legalization.
"Canada has developed the most
sophisticated and compliant medical cannabis program in the world, which makes
Health Canada, arguably, one of the most important data customers in the
industry," said Strainprint CEO, Andrew Muroff. "We are incredibly
proud that they have chosen to work with us as a trusted authority on patient
data."
Khiron Life Sciences Corp. (TSXV:
KHRN) (OTCQB:
KHRNF) announced that
it has completed the EU cosmetic regulatory process for seven Kuida products,
and has received a "no objection" letter from TSXV with respect to
distribution of these products in the UK.
Tejinder Virk, President, Khiron Europe,
commented, "The fulfillment of EU cosmetic regulatory requirements allows
the Company to bring our proven product line into the sophisticated and growing
European skincare market, where we expect to rapidly build and grow Kuida's
market share. We will initially focus on import and marketing in UK, with our
first sales expected in Q1 2020, before expanding to Spain, Germany and the
broader European market, subject to the specific requirements of individual
member states and TSXV approval."
Kuida®, the first consumer brand of
Khiron's wellness business unit, brings the benefits of cannabidiol (CBD) to a
comprehensive portfolio of skin and body care products for women. Kuida was
launched in Colombia in October 2018 through retail, wholesale and online
channels and is now available nationwide and through e-commerce channels. As
the Company expands Kuida® distribution in Europe, the brand will be a featured
exhibitor at Cosmoprof Worldwide Bologna 2020, which attracted over 265,000
visitors in 2019 and is the largest such event to learn more about market
leading products and to place orders.
Aphria Inc. (TSX:
APHA) (NYSE:
APHA) reported its
results for the first quarter ended August 31, 2019.
"We are pleased to report a second
consecutive quarter of profitable growth with strong contribution from our
Canadian cannabis operations. Our success was also driven by our international
business and the strength and growth of our brands, particularly Broken Coast,
despite a small fire at our British Columbia facility at the end of the
quarter. This solid start to the year keeps us on track to achieve our fiscal
year 2020 financial outlook," stated Irwin D. Simon. "Going forward,
we remain focused on our highest-return priorities both in Canada and
internationally as our team furthers the development of our medical and
adult-use cannabis brands to drive growth through innovation and return value
to shareholders."
Some of the key operational highlights
included a net revenue of $126.1 million in the first quarter, an increase of
849% from prior year quarter and a decrease of 2% from the prior quarter, with
the revenue for adult-use cannabis of $20.0 million in the first quarter, an
increase of 8% from the prior quarter. Net income of $16.4 million and adjusted
EBITDA of $1.0 million in the first quarter and ended the quarter with a strong
balance sheet and liquidity, including $464.3 million of cash, cash equivalents
and liquid marketable securities, to fund planned Canadian and International
growth.
Valens GroWorks Corp. (TSXV:
VGW) (OTC:
VGWCF) reported
its financial results for the third quarter of fiscal 2019.
Some of the key financial highlights of
the third quarter included, a revenue increase to $16.5 million, an 87.1%
increase over the second quarter and a 641.4% increase over the first quarter
of 2019, a gross profit increase to $12.8 million, or 77.8% of revenue, for the
third quarter of 2019 compared to $5.1 million or 57.9% of revenue in the
second quarter and an adjusted EBITDA(1) of $9.8 million in the
third quarter, or 59.4% of revenue compared to $2.0 million or 23.0% of revenue
in the second quarter of 2019. The company had a strong balance sheet with
$69.2 million in cash and cash equivalents and short-term investments and a net
working capital position of $84.1 million as at August 31, 2019.
"We are extremely pleased with the
roll-out of our business plan and the continued scale up in the Company's
extraction operations which have allowed us to continue our aggressive quarter
over quarter growth in volumes, revenue, adjusted EBITDA and net income."
said Tyler Robson, CEO of Valens. "The Company's performance in the third
quarter clearly demonstrates our industry leading technical capabilities, the
quality of our products and the earnings power of our platform. While we
anticipate that our margins in future quarters will continue a strong upward
trend from the levels seen in previous quarters, especially as our volumes
continue to ramp and efficiencies are realized, margins in the third quarter
were aided, in part, by a one-time contract opportunity which we do not
anticipate recurring in future quarters. Finally, our net income in the quarter
has made us the most profitable public company in the Canadian cannabis sector
with the highest net income margin (excluding biological asset fair value
adjustments)."
National Access Cannabis Corp. (TSXV:
META) provided
investors with a corporate and retail sales
update. The Company is successfully executing on its growth strategy and has
achieved over $60 million in retail sales since legalization, with cumulative
gross margin of 32%. The Company is targeting to have 40 operating stores by
the end of calendar 2019.
"NAC is already one of the highest
revenue generators in the Canadian cannabis space and by revenue, is the
largest publicly traded recreational cannabis retailer in the country. In a
highly regulated market like Canada, we view owning retail shelf space and the
data gleaned from millions of customer interactions as a pipeline to accessing
customers and developing long-term brands and loyalty," said Mark Goliger,
CEO of NAC. "With one of the largest and most visible networks of retail
storefronts across Canada and a proven track record of repeat customers, NAC is
well-positioned to continue playing a pivotal role in the growing industry. I
am proud of our team for bringing us to over $60 million since federal
legalization and for generating positive and growing Adjusted EBITDA on a
retail basis, all while significantly expanding our store network."
Mr. Goliger added, "As the cannabis
industry continues to evolve, and the introduction of new products is on the
horizon, NAC has a well-defined growth roadmap focused on building shareholder
value. We are focused on building value for shareholders as our team continues
to drive performance from existing stores, introduces enhanced store concepts
and executes on a robust pipeline of new store locations. We believe that
retail is the most strategic segment of the cannabis value chain, as it is the
retailers who are able to interact directly with clients and influence their
purchasing decisions, it is the retailers who have access to data associated
with millions of customer transactions, and it is the retailers who make the
decision as to what products to sell."
CannaRoyalty Corp. d/b/a Origin House (CSE:
OH) (OTCQX:
ORHOF)
announced that the Company has achieved full
integration with the California Cannabis Track-and-Trace system at each of its
six licensed facilities in the state.
The CCTT system, developed by software
vendor, Metrc, uses RFID-enabled tags to track cannabis products through every
stage of the supply chain, from seed to retail sale. Once deployed statewide,
the program will give both regulators and licensees greatly improved visibility
into the movement of cannabis goods in California, while making it harder for black-market
goods to reach consumers.
Since receiving its first provisional
state license from the California Department of Food and Agriculture in March,
2019,
Origin House has worked closely with Metrc and state regulators to implement
CCTT at its cultivation, manufacturing, and distribution facilities. Deployment
of the system at the 17,000-square- West Sacramento distribution hub, operated
by Origin House's distribution arm, Continuum, marked the successful completion
of these efforts.
"Our team has long supported
CCTT-Metrc as a cornerstone of California's regulatory and consumer-protection
strategies," said Lee Dorkin, Head of California Operations at Origin
House. "We are proud to be among the first vertically-integrated operators
to complete deployment of the system at such a large scale. Our success in
doing so reaffirms Origin House's commitment to being an industry leader in
compliance and product quality."
THC BioMed Intl Ltd. (CSE:
THC) announced that
Health Canada has amended its licence to enable THC BioMed to sell cannabis oil
products.
"October 17th marks a
significant turn for the cannabis industry as we welcome the introduction of
edibles. THC BioMed is excited to participate in this momentous occasion with
the granting of our oil licence," commented John Miller, CEO of THC
BioMed, "We also will be filing an application to add the sale of
extracts, topicals and edibles to our licence in the next few days."
"We are proud to introduce a
brand-new product to the cannabis market, THC Kiss, a proprietary invention of
THC BioMed. This is a unique product and it is not something that can be found
on the existing gray or legal markets," said Mr. Miller.
THC Kiss, when approved, will be
available through authorized provincial distributers and to THC BioMed's
registered patients.
Namaste Technologies Inc. (TSXV:
N) (OTC:
NXTTF) announced that
CannMart Inc., a wholly owned subsidiary of Namaste, has received approval from
Health Canada for an amendment to its license allowing it to offer cannabis oil
concentrates on its online marketplace, CannMart.com.
"The long-awaited Health Canada
approval we just received, is pivotal as it allows us to participate in the
cannabis oils market today, and sets the stage for our presence in the edibles,
extracts and topicals markets, pending their legalization and regulation
anticipated to occur this week," said Meni Morim, CEO of Namaste
Technologies Inc. "The amended sales license opens the door to a wide
range of new cannabis products and related revenue streams and fulfills a key
strategy milestone."
The amendment to CannMart's cannabis
sales license allows CannMart to offer cannabis oils to its registered medical
patients immediately and positions CannMart to leverage Canada's "Cannabis
2.0" market opportunity when cannabis edibles, extracts, and topicals
become legal for recreational use. In a recent report, the consulting firm
Deloitte estimates that the Canadian market for edibles and alternative
cannabis products to be worth up to C$2.7 billion annually.
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement to
buy products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also
available on iTunes, Spotify, Google
Play Music, Stitcher, Spreaker, YouTube
via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing
Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast and column, Cleantech and
Climate Change , Exploring Mining
the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment